Financhill
Sell
9

IMVT Quote, Financials, Valuation and Earnings

Last price:
$19.01
Seasonality move :
0.73%
Day range:
$18.57 - $19.60
52-week range:
$17.65 - $35.97
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
9.05x
Volume:
661.9K
Avg. volume:
1.3M
1-year change:
-40.95%
Market cap:
$3.2B
Revenue:
--
EPS (TTM):
-$2.62

Earnings Data

Next earnings date for IMVT
May 29
2025
Most recent earnings per share
-$0.76
Missed by $0.01
(Feb 6/2025)
Consensus Estimate
-$0.75
(Feb 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

IMVT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/29/2025 Q1 -- -- -- -$0.72 --
02/06/2025 Q4 -- -- -$0.76 -$0.75 -$0.01
11/07/2024 Q3 -- -- -$0.74 -$0.61 -$0.13
08/06/2024 Q2 -- -- -$0.60 -$0.52 -$0.08
05/29/2024 Q1 -- -- -$0.52 -$0.43 -$0.09
02/12/2024 Q4 -- -- -$0.36 -$0.42 $0.06
11/09/2023 Q3 -- -- -$0.45 -$0.46 $0.01
08/10/2023 Q2 -- -- -$0.57 -$0.44 -$0.13
05/22/2023 Q1 -- -- -$0.46 -$0.41 -$0.05
02/03/2023 Q4 -- -- -$0.49 -$0.37 -$0.12
11/04/2022 Q3 -- -- -$0.41 -$0.36 -$0.05
08/05/2022 Q2 -- -- -$0.35 -$0.40 $0.05
06/08/2022 Q1 -- -- -$0.41 -$0.35 -$0.06
02/04/2022 Q4 -- -- -$0.36 -$0.31 -$0.05
11/05/2021 Q3 -- -- -$0.35 -$0.27 -$0.08
08/06/2021 Q2 -- -- -$0.31 -$0.32 $0.01
06/01/2021 Q1 -- -- -$0.28 -$0.34 $0.06
02/16/2021 Q4 -- -- -$0.32 -$0.25 -$0.07
11/12/2020 Q3 -- -- -$0.25 -$0.30 $0.05
08/12/2020 Q2 -- -- -$0.38 -$0.32 -$0.06
06/29/2020 Q1 -- -- -$0.38 -$0.28 -$0.10
02/14/2020 Q4 -- -- -$0.28 -$0.26 -$0.03
09/30/2019 Q3 -- -- $0.01 -- --
08/12/2019 Q2 -- -- $0.01 -- --
06/12/2019 Q1 -- -- -$0.00 -- --

Immunovant Earnings Questions

  • How Much did Immunovant Generate in Revenue Last Quarter?

    Immunovant reported -- worth of top line sales in its most recent quarter.

  • Did Immunovant Beat Earnings Last Quarter?

    Immunovant announced earnings per share of -$0.76 which represents a miss of analyst forecast a -$0.75 per share.

  • Is Immunovant Profitable?

    Immunovant reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Immunovant EPS Next Year?

    Immunovant's earnings are forecast to decrease from -$1.88 per share to -$1.74 per share next year representing a decrease of -56.07%.

  • When is Immunovant's Earnings Date?

    Immunovant's next earnings date is May 29, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

3 Safest Stocks to Buy Now
3 Safest Stocks to Buy Now

With the S&P 500 now in correction and stocks selling…

Tesla Stock: The Bear Case
Tesla Stock: The Bear Case

The recent stock market drop has been a punishing time…

Is VUG a Good ETF to Buy?
Is VUG a Good ETF to Buy?

For the last few years, earnings growth from the tech…

Stock Ideas

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 34x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Sell
47
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Alerts

Sell
5
CABO alert for Mar 14

Cable One [CABO] is down 2.23% over the past day.

Sell
38
ADBE alert for Mar 14

Adobe [ADBE] is up 2.25% over the past day.

Sell
29
CAR alert for Mar 14

Avis Budget Group [CAR] is up 6.29% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock